Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Veronica Steri"'
Autor:
Elliot Stieglitz, Aaron C Logan, Emilio Ramos, William C Temple, Matthew A Nix, Akul Naik, Adila Izgutdina, Benjamin J Huang, Gianina Wicaksono, Paul Phojanakong, Juan Antonio Camara Serrano, Elizabeth P Young, Fernando Salangsang, Veronica Steri, Simayijiang Xirenayi, Michelle Hermiston, Arun P Wiita
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Approximately 50% of patients who receive anti-CD19 CAR-T cells relapse, and new immunotherapeutic targets are urgently needed. We recently described CD72 as a promising target in B-cell malignancies and developed nanobody-based CAR-T cell
Externí odkaz:
https://doaj.org/article/2d39e3cf7d6f4d60aeb1265961906c97
Autor:
Avisek Majumder, Manbir Sandhu, Debarko Banerji, Veronica Steri, Adam Olshen, Mark M. Moasser
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract HER2 and HER3 play key driving functions in the pathophysiology of HER2-amplified breast cancers, but this function is less well characterized in other cancers driven by HER2 amplification. This study aimed to explore the role of HER2 and HE
Externí odkaz:
https://doaj.org/article/c397830c5fdc4bd9aad3949e664aac3c
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
Autor:
Shion A. Lim, Jie Zhou, Alexander J. Martinko, Yung-Hua Wang, Ekaterina V. Filippova, Veronica Steri, Donghui Wang, Soumya G. Remesh, Jia Liu, Byron Hann, Anthony A. Kossiakoff, Michael J. Evans, Kevin K. Leung, James A. Wells
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 4 (2022)
Extracellular proteolysis is frequently dysregulated in disease and can generate proteoforms with unique neoepitopes not found in healthy tissue. Here, we demonstrate that Abs that selectively recognize a proteolytic neoepitope on CUB domain containi
Externí odkaz:
https://doaj.org/article/185e24f5d7a047799beb370607485344
Autor:
Tim S. Ellison, Samuel J. Atkinson, Veronica Steri, Benjamin M. Kirkup, Michael E. J. Preedy, Robert T. Johnson, Christiana Ruhrberg, Dylan R. Edwards, Jochen G. Schneider, Katherine Weilbaecher, Stephen D. Robinson
Publikováno v:
Disease Models & Mechanisms, Vol 8, Iss 9, Pp 1105-1119 (2015)
Anti-angiogenic treatments against αvβ3-integrin fail to block tumour growth in the long term, which suggests that the tumour vasculature escapes from angiogenesis inhibition through αvβ3-integrin-independent mechanisms. Here, we show that suppre
Externí odkaz:
https://doaj.org/article/3c3312f97ec54dd2b530c35f1517aff2
Autor:
Jonathan Chou, Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar, Jun Zhu, Tanushree Shenoy, Kai Trepka, Troy M. Robinson, Veronica Steri, Jiaoti Huang, Yuzhuo Wang, Eric J. Small, Emily Chan, Bradley A. Stohr, Alan Ashworth, Brant Delafontaine, Sylvie Rottey, Keegan S. Cooke, Nooshin Hashemi Sadraei, Brian Yu, Mark Salvati, Julie M. Bailis, Felix Y. Feng, Robert R. Flavell, Rahul Aggarwal
Publikováno v:
Cancer Research. 83:301-315
Effective treatments for de novo and treatment-emergent small-cell/neuroendocrine (t-SCNC) prostate cancer represent an unmet need for this disease. Using metastatic biopsies from patients with advanced cancer, we demonstrate that delta-like ligand 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd84ff0076818d35ace7788f4b37165
https://doi.org/10.1158/0008-5472.can-22-1433
https://doi.org/10.1158/0008-5472.can-22-1433
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Alternative strategies are needed for patients with B-cell malignancy relapsing after CD19-targeted immunotherapy. Here, cell surface proteomics revealed CD72 as an optimal target for poor-prognosis KMT2A/MLL1-rearranged (MLLr) B-cell acute lymphobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eda55a5274e3677f255a2fad22066d9
https://doi.org/10.1158/2159-8290.c.6548995.v1
https://doi.org/10.1158/2159-8290.c.6548995.v1
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Supplementary Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071cd4a9ceee3e0f3be7d0956260a267
https://doi.org/10.1158/2159-8290.22539136.v1
https://doi.org/10.1158/2159-8290.22539136.v1
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Supplementary Figure from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d17db5e546d5631791798d1c469ce4
https://doi.org/10.1158/2159-8290.22539127
https://doi.org/10.1158/2159-8290.22539127
Autor:
Rahul Aggarwal, Robert R. Flavell, Felix Y. Feng, Julie M. Bailis, Mark Salvati, Brian Yu, Nooshin Hashemi Sadraei, Keegan S. Cooke, Sylvie Rottey, Brant Delafontaine, Alan Ashworth, Bradley A. Stohr, Emily Chan, Eric J. Small, Yuzhuo Wang, Jiaoti Huang, Veronica Steri, Troy M. Robinson, Kai Trepka, Tanushree Shenoy, Jun Zhu, Anil P. Bidkar, Fei Lee, Michelle L. Badura, Sinan Wang, Emily A. Egusa, Jonathan Chou
Effective treatments for de novo and treatment-emergent small-cell/neuroendocrine (t-SCNC) prostate cancer represent an unmet need for this disease. Using metastatic biopsies from patients with advanced cancer, we demonstrate that delta-like ligand 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637631395292baf4918a236d81eca75d
https://doi.org/10.1158/0008-5472.c.6514325
https://doi.org/10.1158/0008-5472.c.6514325
Autor:
Rahul Aggarwal, Robert R. Flavell, Felix Y. Feng, Julie M. Bailis, Mark Salvati, Brian Yu, Nooshin Hashemi Sadraei, Keegan S. Cooke, Sylvie Rottey, Brant Delafontaine, Alan Ashworth, Bradley A. Stohr, Emily Chan, Eric J. Small, Yuzhuo Wang, Jiaoti Huang, Veronica Steri, Troy M. Robinson, Kai Trepka, Tanushree Shenoy, Jun Zhu, Anil P. Bidkar, Fei Lee, Michelle L. Badura, Sinan Wang, Emily A. Egusa, Jonathan Chou
FigureS7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834d9df1db0096d6d2410b8c2644c6e6
https://doi.org/10.1158/0008-5472.22433267
https://doi.org/10.1158/0008-5472.22433267